Results of Elections Give Pharmaceutical Industry New Influence in Congress

Vaccination News Home Page

http://query.nytimes.com/search/abstract?res=FB0810FA3F5D0C728EDDA80994DA404482

NATIONAL DESK | November 21, 2002, Thursday
Results of Elections Give Pharmaceutical Industry New Influence in Congress

By ROBERT PEAR and RICHARD A. OPPEL Jr. (NYT) 1169 words
Late Edition - Final, Section A, Page 34, Column 1

LEAD PARAGRAPH - Having spent more than $30 million to help elect their allies to Congress, the major drug companies are devising ways to capitalize on their electoral success by securing favorable new legislation and countering the pressure that lawmakers in both parties feel to lower the cost of prescription drugs, industry officials say.

The industry's hand appears stronger now than at any other time in recent years, a result of its large donations to political parties and candidates and millions of dollars spent on television advertising by industry-financed groups. The money was spent overwhelmingly on behalf of Republicans, who now control both houses of Congress.

 


You can purchase this article:

As a single article for $2.95
As part of an Article 4 Pack for $ 7.95 - A 33% savings.
As part of an Article 10 Pack for $15.95 - A 46% savings.
As part of an Article 25 Pack for $25.95 - A 65% savings.

 

Click here to purchase article if you already own an archive article pack.

Premium Archive articles do not currently include photos, charts, or graphics of any kind.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.